| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/12/2011 | US20110110931 Methods for Detecting and Monitoring Circulating Cancer Stem Cells |
| 05/12/2011 | US20110110930 Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects |
| 05/12/2011 | US20110110929 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 05/12/2011 | US20110110928 Fc variants with altered binding to fcrn |
| 05/12/2011 | US20110110927 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 05/12/2011 | US20110110926 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 05/12/2011 | US20110110925 Compositions and Methods for the Treatment and Diagnosis of Cancer |
| 05/12/2011 | US20110110924 Resistin as a Marker and Therapeutic Target for Cardiovascular Disease |
| 05/12/2011 | US20110110923 Fish assay for eml4 and alk fusion in lung cancer |
| 05/12/2011 | US20110110889 Raf inhibitor compounds and methods of use thereof |
| 05/12/2011 | US20110110886 Small molecule inhibitors of autotaxin and methods of use |
| 05/12/2011 | US20110110885 Bioactive Depside and Anthocyanin Compounds, Compositions, and Methods of Use |
| 05/12/2011 | US20110110883 Methods of altering an immune response induced by cpg oligodeoxynucleotides |
| 05/12/2011 | US20110110861 Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells |
| 05/12/2011 | US20110110859 Protein |
| 05/12/2011 | US20110110857 Mutant forms of chlamydia htra |
| 05/12/2011 | US20110110854 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules |
| 05/12/2011 | US20110110852 Multivalent Antibodies and Uses Therefor |
| 05/12/2011 | US20110110851 Multivalent Immunoglobulin-Based Bioactive Assemblies |
| 05/12/2011 | CA2816437A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | CA2816401A1 Generation of antigenic virus-like particles through protein-protein linkages |
| 05/12/2011 | CA2779839A1 T-cell stimulating protein b and methods of use |
| 05/12/2011 | CA2779645A1 Vaccines for the treatment of neoplasias based on viral capsids of birnavirus containing human papillomavirus antigens |
| 05/12/2011 | CA2779515A1 Haemophilus parasuis polypeptides and methods of use |
| 05/12/2011 | CA2779384A1 Engineered anti-tslp antibody |
| 05/12/2011 | CA2778552A1 Treatment of cancer involving mutated kras or braf genes |
| 05/12/2011 | CA2778112A1 Human il-23 antigen binding proteins |
| 05/12/2011 | CA2776563A1 Immunoconjugates comprising poxvirus-derived peptides and antibodies against antigen-presenting cells for subunit-based poxvirus vaccines |
| 05/12/2011 | CA2774039A1 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
| 05/12/2011 | CA2769996A1 Plasmodium falciparum sporozoite and liver stage antigens |
| 05/11/2011 | EP2320233A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 05/11/2011 | EP2319931A1 Extracellular matrix-binding proteins from staphylococcus aureus |
| 05/11/2011 | EP2319917A2 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319868A1 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 05/11/2011 | EP2319867A1 Human monoclonal nicotine specific antibodies |
| 05/11/2011 | EP2319861A1 A method for identification, isolation and production of antigens to a specific pathogen |
| 05/11/2011 | EP2319860A2 Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes |
| 05/11/2011 | EP2319536A1 Inhibiting CAV3 isoforms and the delta25B splice varients for the diagnosis and treatment of cancer |
| 05/11/2011 | EP2319535A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 05/11/2011 | EP2319534A1 Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 05/11/2011 | EP2319533A1 Immunity-inducing agent and method for detection of cancer |
| 05/11/2011 | EP2319532A1 Recombinant dengue virus containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 3, or 4 |
| 05/11/2011 | EP2319529A1 Methods for treating congestive heart failure |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2318537A1 Optimized promoter sequence |
| 05/11/2011 | EP2318530A1 New influenza virus immunizing epitope |
| 05/11/2011 | EP2318515A1 Vaccines against clostridium difficile and methods of use |
| 05/11/2011 | EP2318442A1 Treatment of autoimmune and inflammatory disease |
| 05/11/2011 | EP2318440A1 Antibodies binding to adrenomedullin receptors and uses thereof as drugs |
| 05/11/2011 | EP2318439A2 Methods of altering peripheral b cell populations and uses thereof |
| 05/11/2011 | EP2318438A1 Anti-p2x7 peptiden und epitopen |
| 05/11/2011 | EP2318437A2 Method for treating multiple sclerosis patients with anti-il2r antibodies |
| 05/11/2011 | EP2318430A2 Polyvalent vaccine |
| 05/11/2011 | EP2318406A1 Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| 05/11/2011 | EP2318048A1 Structural variants of antibodies for improved therapeutic characteristics |
| 05/11/2011 | EP2318047A1 Probiotics, secretory iga and infection |
| 05/11/2011 | EP2318046A1 Probiotics, secretory iga and inflammation |
| 05/11/2011 | EP2318045A1 Modification of allergens for immunotherapy |
| 05/11/2011 | EP2318044A1 Influenza vaccines |
| 05/11/2011 | EP2318043A2 Influenza hemagglutinin and neuraminidase variants |
| 05/11/2011 | EP2318042A1 Vaccine against hpv |
| 05/11/2011 | EP2318041A1 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies |
| 05/11/2011 | EP2318040A1 Therapy targeting cancer stem cells |
| 05/11/2011 | EP2318039A2 Goodpasture antigen binding protein and its detection |
| 05/11/2011 | EP2318028A2 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 05/11/2011 | EP2318012A2 Methods and compositions for treating and preventing autoimmune diseases |
| 05/11/2011 | EP2318002A2 Use of mtor inhibitors to enhance t cell immune responses |
| 05/11/2011 | EP2317982A2 Methods of processing compositions containing microparticles |
| 05/11/2011 | EP1996716B1 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| 05/11/2011 | EP1827504B1 Recombinant bcg strains with enhanced ability to escape the endosome |
| 05/11/2011 | EP1774037B1 Assays and methods using biomarkers |
| 05/11/2011 | EP1678209B1 Antibodies to nik, their preparation and use |
| 05/11/2011 | EP1456398B1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna |
| 05/11/2011 | EP1449850B9 Human cdr-grafted antibodies and antibody fragments thereof |
| 05/11/2011 | EP1381280B1 Viral vectors and their use in therapeutic methods |
| 05/11/2011 | EP1161227B1 Microparticles for delivery of nucleic acid |
| 05/11/2011 | EP0885002B1 Materials and methods for enhancing cellular internalization |
| 05/11/2011 | CN1852735B Vaccine formulations comprising an oil-in-water emulsion |
| 05/11/2011 | CN1692156B Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 05/11/2011 | CN1688695B New dendritic cell co stimulatory molecules |
| 05/11/2011 | CN1599623B Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 05/11/2011 | CN102056946A Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| 05/11/2011 | CN102056944A Anti-inflammatory agents |
| 05/11/2011 | CN102056627A Use of histamine H4 antagonist for the treatment of post-operative adhesions |
| 05/11/2011 | CN102056626A Detection and tratment of pancreatic, ovarian and other cancers |
| 05/11/2011 | CN102056625A Non-invasive systems and methods for in-situ photobiomodulation |
| 05/11/2011 | CN102056624A Vaccines for prevention and treatment of addiction |
| 05/11/2011 | CN102056623A Immunogenic composition |
| 05/11/2011 | CN102056622A Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| 05/11/2011 | CN102056618A Compositions and methods for preventing or treating AIDS |
| 05/11/2011 | CN102056617A Inhibition of angiogenesis |
| 05/11/2011 | CN102050879A Anti-human CD20 humanized antibody and preparation method and application thereof |
| 05/11/2011 | CN102050878A Anti-human CD20 humanized antibody and preparation method and application thereof |
| 05/11/2011 | CN102050877A Anti-human CD20 humanized antibody, preparation method and application thereof |
| 05/11/2011 | CN102049048A Method of treatment or prophylaxis |
| 05/11/2011 | CN102049045A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 05/11/2011 | CN102049044A Calcium supplementing composition preparation for improving calcium absorption |
| 05/11/2011 | CN102049043A Infectious bovine rhinotracheitis vaccine and preparation method thereof |
| 05/11/2011 | CN102048712A Stable film agent medicinal composition containing allergen and preparation method thereof |